Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessing the Molecular Heterogeneity of Prostate Cancer Biopsy Sampling: Insights from the MAST Trial.
Ajami T, Yu H, Porto JG, Prakash NS, Williams A, Avda Y, Malpani A, Mendiola DF, Freitas PFS, Khandekar A, Swain S, Gaston S, Mahal B, Cortizas E, Szczotka Z, Gerard T, Kava B, Stoyanova R, Kryvenko ON, Castillo P, Ritch CR, Nahar B, Gonzalgo ML, Pollack A, Parekh DJ, Punnen S. Ajami T, et al. Among authors: kava b. Eur Urol Focus. 2024 Dec 10:S2405-4569(24)00256-6. doi: 10.1016/j.euf.2024.11.012. Online ahead of print. Eur Urol Focus. 2024. PMID: 39665894
Reclassification Rates of Patients Eligible for Active Surveillance After the Addition of Magnetic Resonance Imaging-Ultrasound Fusion Biopsy: An Analysis of 7 Widely Used Eligibility Criteria.
Nahar B, Katims A, Barboza MP, Soodana Prakash N, Venkatramani V, Kava B, Satyanarayana R, Gonzalgo ML, Ritch CR, Parekh DJ, Punnen S. Nahar B, et al. Among authors: kava b. Urology. 2017 Dec;110:134-139. doi: 10.1016/j.urology.2017.08.016. Epub 2017 Aug 24. Urology. 2017. PMID: 28842208
Heterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted Biopsy.
Punnen S, Stoyanova R, Kwon D, Reis IM, Soodana-Prakash N, Ritch CR, Nahar B, Gonzalgo ML, Kava B, Liu Y, Arora H, Gaston SM, Castillo Acosta RP, Pra AD, Abramowitz M, Kryvenko ON, Davicioni E, Pollack A, Parekh DJ. Punnen S, et al. Among authors: kava b. J Urol. 2021 May;205(5):1344-1351. doi: 10.1097/JU.0000000000001559. Epub 2020 Dec 24. J Urol. 2021. PMID: 33356482 Free PMC article.
Malakoplakia of the prostate diagnosed on multiparametric-MRI ultrasound fusion guided biopsy: A case report and review of the literature.
Velasquez MC, Taylor Smith PJ, Prakash NS, Kava B, Kryvenko ON, Castillo-Acosta R, Bittencourt LK, Gonzalgo ML, Ritch C, Parekh DJ, Punnen S. Velasquez MC, et al. Among authors: kava b. Urol Case Rep. 2017 Nov 21;18:94-96. doi: 10.1016/j.eucr.2017.11.009. eCollection 2018 May. Urol Case Rep. 2017. PMID: 29785385 Free PMC article. No abstract available.
Optimizing patient's selection for prostate biopsy: A single institution experience with multi-parametric MRI and the 4Kscore test for the detection of aggressive prostate cancer.
Punnen S, Nahar B, Soodana-Prakash N, Koru-Sengul T, Stoyanova R, Pollack A, Kava B, Gonzalgo ML, Ritch CR, Parekh DJ. Punnen S, et al. Among authors: kava b. PLoS One. 2018 Aug 9;13(8):e0201384. doi: 10.1371/journal.pone.0201384. eCollection 2018. PLoS One. 2018. PMID: 30092002 Free PMC article.
Reply by Authors.
Ritch CR, Velasquez MC, Kwon D, Becerra MF, Soodana-Prakash N, Atluri VS, Almengo K, Alameddine M, Kineish O, Kava BR, Punnen S, Parekh DJ, Gonzalgo ML. Ritch CR, et al. J Urol. 2020 Mar;203(3):511. doi: 10.1097/JU.0000000000000593.02. Epub 2019 Dec 19. J Urol. 2020. PMID: 31854258 No abstract available.
A multi-institutional study of 1,111 men with 4K score, multiparametric magnetic resonance imaging, and prostate biopsy.
Thomas J, Atluri S, Zucker I, Reis I, Kwon D, Kim E, Tewari A, Patel V, Wagaskar V, Konety B, Kasraeian A, Czarniecki S, Thoreson G, Soodana-Prakash N, Ritch C, Nahar B, Gonzalgo M, Kava B, Parekh D, Punnen S. Thomas J, et al. Among authors: kava b. Urol Oncol. 2023 Oct;41(10):430.e9-430.e16. doi: 10.1016/j.urolonc.2023.07.001. Epub 2023 Aug 4. Urol Oncol. 2023. PMID: 37544833
78 results